|
| March is shaping up to be the Dow’s worst first quarter on the history books due to the coronavirus crisis. The Dow is up 20% from its sell-off low reached on March 23, but is still down 12% in March marking its worst month since October 2008, and is down nearly 23% year-to-date. The S&P 500 is ending the quarter down roughly 20%. Oil is also on track to register its worst quarterly performance on record as global demand for crude plummets. Brent crude fell to its l... |
| Owens & Minor (NYSE: OMI): Owens & Minor shares are up nearly 44% over the last week after the company said it has ramped up production of face masks and other medical gear to keep u with demand for personal protective equipment amid the coronavirus crisis. CEO Ed Pesicka told CNBC’s Jim Cramer on Friday, “We are in the process of actually expanding capacity, but that’... |
The time looks right to buy TSNTSN is a globally positioned company that I think fits into a useful, defensive niche. The Food Products industry has proven to be a pocket of the market this month that investors have taken interest in, as social distancing and self-isolation have become more and more necessary. That has prompted consumers to put a lot of attention on making sure they have enough basic supplies at home to get through the foreseeable future. I think that has played a big role in TSN’s short-term rebound, bu... |
| |
|
|
Featured StockNovavax, Inc. (NVAX) – Buy Target – $14.50 or betterNovavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company’s lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein recombinant nanoparticle vaccine with aluminum phosphate as an adjuvant that is in Phase III clinical trial to protect infants from RSV disease through maternal immunization; a... |
Other Top Stories |
| |
Trend Following PicksAll Picks |
Reversal PicksAll Picks |
Already subscribed to our premium service?Click here to Login.Not a TradersPro subscriber yet?Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits |
 |
This email was sent to its028@gmail.com by Investiv, LLC
Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro
Investing is Inherently Risky
There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.
Hypothetical Results Are Reported
Results and examples used in the Company's advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage.
The Company's simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading.
Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company's software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Offers Disinterested Commentary and Analysis
The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one's own recommendations.
The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company's principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase.
Disclaimers, Terms & Conditions | Privacy Policy
Copyright © 2019
没有评论:
发表评论